In a recent published report, Kenneth Research has updated the market report for Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market for 2021 till 2030. Report further now discusses; the various strategies to be adopted or being adopted by the business players across the globe at various levels in the value chain. In the view of the global economic slowdown, we further estimated that China, India, Japan and South Korea to recover fastest amongst all the countries in the Asian market. Germany, France, Italy, Spain to take the worst hit and this hit is expected to be regain 25% by the end of 2021- Positive Growth in the economic demand and supply.
U.S. Market recovers fast; In a release on May 4th 2021, the U.S. Bureau and Economic Analsysis and U.S. Census Bureau mentions the recovery in the U.S. International trade in March 2021. Exports in the country reached $200 billion, up by $12.4 billion in Feb 2021. Following the continuous incremental trend, imports tallied at $274.5 billion, picked up by $16.4 billion in Feb 2021. However, as COVID19 still haunts the economies across the globe, year-over-year (y-o-y) avergae exports in the U.S. declined by $7.0 billion from March 2020 till March 2021 whilest imports increased by $20.7 billion during the same time. This definitely shows how the market is trying to recover back and this will have a direct impact on the Healthcare/ICT/Chemical industries, creating a huge demand for Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market products.
Download Sample PDF of this Report :- https://www.kennethresearch.com/sample-request-10352351
Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Highlights Over 2020 – 2030
The Europe pharmaceutical contract development and manufacturing organization (CDMO) market is estimated to garner a revenue of USD 39920.2 Million by the end of 2030, by growing at a CAGR of 6.7% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market in the region generated a revenue of USD 21133.3 Million. The growth of the market can be attributed primarily to the growing prevalence of different types of chronic diseases in the region, such as cancer, diabetes, and cardiovascular diseases amongst others, and therefore the need for advanced pharmaceutical drugs that can help in the treatment of these deadly diseases. According to the statistics by the European Commission, in the year 2018, there were 1.68 Million deaths in the European Union due to the diseases of the circulatory system. Moreover, according to the statistics by the World Health Organization (WHO), the European region registered about 60 Million people above the age of 25 years that had diabetes. Additionally, the statistics also stated that between the year 2005 and 2030, the number of deaths caused due to diabetes in the region is estimated to double.
The growth of the Europe pharmaceutical contract development and manufacturing organization (CDMO) market can also be attributed to the growing advancements in medical research and the need for high potency active pharmaceutical ingredients (HPAPI). Besides this, the rise in demand for antibody-drug conjugates and the need amongst the pharmaceutical companies for developing advanced novel drugs are some of the additional factors projected to contribute to the growth of the market in the coming years.
Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Regional Synopsis
The Europe pharmaceutical contract development and manufacturing organization (CDMO) market is segmented on the basis if countries into Germany, United Kingdom, France, Italy, Spain, Russia, and the Rest of Europe. The market in Italy is anticipated to garner the largest revenue of USD 8942.1 Million by the end of 2030, up from a revenue of USD 4860.7 Million in the year 2020. The growth of the market in the nation can primarily be attributed to the presence of several pharmaceutical companies who are producers of active pharmaceutical ingredients (APIs), as well as for the presence of an established network of pharmaceutical manufacturing companies who deal with different types of pharmaceutical drugs. According to the statistics by the International Trade Administration (ITA) of the United States Department of Commerce, in the year 2018, there were 641 biotechnology companies in Italy, of which, 320 were red biotech companies. Moreover, the total turnover of the biotechnology companies in the nation registered USD 13666 Million in the same year, while investments in R&D by these companies amounted to USD 2428 Million in that year.
Request Free Sample Copy :-https://www.kennethresearch.com/sample-request-10352351
Growth Drivers and Challenges Impacting the Growth of the Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market
Growth Drivers
- Growing Demand for High Potency Active Pharmaceutical Ingredients (HPAPI) Amongst Pharmaceutical Organizations
- Rising Number of Medical Research and Development Activities
- Increasing Prevalence of Chronic Diseases in the Region
Challenges
- Stringent Government Regulations
- Loss of Intellectual Property
Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Segmentation Synopsis
The Europe pharmaceutical contract development and manufacturing organization (CDMO) market is segmented by category into pharmaceutical industry and biopharmaceutical industry, out of which, the pharmaceutical industry is anticipated to garner the largest revenue by the end of 2030 and also grow with a CAGR of 6.5% during the forecast period. By therapeutic application, the market is segmented into infectious diseases, oncology, metabolic disorders, cardiovascular disorders, central nervous system, pulmonary disorders, gastrointestinal disorders, and other therapeutic applications. Out of these, the oncology segment is anticipated to garner the largest revenue of USD 10609.8 Million by the end of 2030, up from a revenue of USD 5441.8 Million in the year 2020. By end-user, the market is segmented into pharmaceutical & biopharmaceutical companies, medical device companies, and academic institutes. Out of these, the pharmaceutical & biopharmaceutical companies segment is anticipated to garner the largest revenue of USD 27756.1 Million by the end of 2030, up from a revenue of USD 14771.1 Million in the year 2020. By service type, the market is segmented into pharmaceutical contract manufacturing organization (CMO), and pharmaceutical contract research organization (CRO), out of which, the pharmaceutical CMO segment is projected to garner the largest revenue by the end of 2030 and also grow with the highest CAGR of 6.9% during the forecast period.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the Europe pharmaceutical contract development and manufacturing organization (CDMO) market that are included in our report are Hangzhou Tigermed Consulting Co., Ltd, ICON plc, IQVIA Inc., LSK Global Pharma Services Co., Ltd., Parexel International Corporation, PPD Inc., Almac Group, Quanticate International Limited, Samsung Biologics, Syneos Health, Wuxi Apptec Co., Ltd., Delpharm Holding, Evonik Industries AG, Siegfried Holding AG, Aenova Group, Baxter International, Inc., Boehringer Ingelheim International GmbH, Catalent, Inc., Famar Group, Jubilant Pharmova Limited, Lonza, CMIC HOLDINGS Co., LTD., Labcorp Drug Development, Thermo Fisher Scientific Inc., Pfizer Inc., Recipharm AB, Vetter Pharma-Fertigung GmbH & Co. KG, Charles River Laboratories International, Inc., and others.
Download Sample PDF of this Report :- https://www.kennethresearch.com/sample-request-10352351
About Kenneth Research
Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation
Contact Us
Kenneth Research
Email : Sales@kennethresearch.com
Phone: +1 313 462 0609
————————New Latest Trending Reports——————————
Global Trace and Track Solutions Market
Global Laboratory Information System Market
Global Bronchodilators Market
Global Cervical Forceps Market
Global Pneumonia Vaccine Market
Global Lung Biopsy Device Market
Global Medical Lasers Market
